Dr Nicholas S Hopkinson

Dr Nick S Hopkinson

Contact details

Dr Nick S Hopkinson

Clinical Senior Lecturer & Hon Consultant
National Heart & Lung Institute

Tel: +44 (0)20 7349 7776
Email: Email address for Dr Nick S Hopkinson

Dr Nicholas S Hopkinson

Nick Hopkinson is a Clinical Senior Lecturer at Imperial College as well as an Honorary Consultant Chest Physician at The Royal Brompton Hospital. He qualified in Medicine at Cambridge and The London Hospital Medical College and went on to train in Respiratory and General Internal Medicine at St George’s and St Thomas’ Hospitals. He is clinical lead for chronic obstructive pulmonary disease (COPD) at The Royal Brompton Hospital and runs a tertiary referral advanced COPD clinic with Professor Mike Polkey and Dr Matthew Hind where patients are assessed for novel treatments for their disease including endobronchial emphysema therapies. He has established a smoking cessation clinic within the trust and is responsible for developing pulmonary rehabilitation services. Service development work includes the development of a COPD discharge care bundle working with the NW London CLAHRC. 

His major research interest is the causes of exercise limitation and reduced physical activity in patients with COPD. His publications have addressed the influence of genetic polymorphisms, corticosteroid therapy and the role of acute exacerbations in skeletal muscle impairment in this condition. He has also published work on the impact of bronchoscopic lung volume reduction on dynamic hyperinflation in patients with COPD and on transcranial magnetic stimulation of the diaphragm motor cortex in health and disease. He is a work package lead for the EU/IMI PROactive project developing a patient reported outcome for physical activity in COPD.

His work has been funded by The Medical Research Council, Wellcome Trust, The European Union, The British Lung Foundation and The Moulton Foundation. He works closely with Professor Mike Polkey and together with Professor John Moxham at King’s College Hospital and Dr Nick Hart at St Thomas’ they make up the London Respiratory Muscle Group which has undertaken a considerable body of collaborative research. Other external collaborations are with Professor Hugh Montgomery at UCH and he has also worked with Iranian physicians to improve the care, in particular through pulmonary rehabilitation, of victims of mustard gas from the Iran Iraq war in the 1980’s. Techniques employed include invasive measurement of respiratory pressures, cardiopulmonary exercise testing and the use of magnetic nerve stimulation to obtain non-volitional measures of muscle function.

Within Imperial College he is involved in research with The Centre for Pervasive Sensing to develop more sophisticated integrated physiology and activity sensors to monitor patients in their home environment. 

He is a Fellow of The Royal College of Physicians and is on the Council of The British Thoracic Society where he serves on the Science and Research Committee. He is the editor of the BTS newsletter, a spokesperson on COPD for the British Lung Foundation and was a medical advisor for ‘The Smoke House’ TV programme produced by The BBC.

 

 

Selected Publications


Journals

  • Hopkinson NS; Englebretsen C; Cooley N; Kennie K; Lim M; Woodcock T; Laverty AA; Wilson S; et alElkin SL; Caneja C; Falzon C; Burgess H; Bell D; Lai D. (Jan 2012). Designing and implementing a COPD discharge care bundle. Thorax. 67:90-92. DOI.
  • Dodd JW; Hogg L; Nolan J; Jefford H; Grant A; Lord VM; Falzon C; Garrod R; et alLee C; Polkey MI; Jones PW; Man WD; Hopkinson NS. (May 2011). The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax. 66:425-429. Author weblink DOI.
  • Hopkinson NS; Shah PL; Polkey MI. (27 Jan 2011). Endobronchial valves for emphysema. N Engl J Med. 364:381-382. Author weblink DOI.
  • Hopkinson NS; Kemp SV; Toma TP; Hansell DM; Geddes DM; Shah PL; Polkey MI. (Jun 2011). Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 37:1346-1351. Author weblink DOI.
  • Falzon C; Elkin SL; Kelly JL; Lynch F; Blake ID; Hopkinson NS. (Jul 2011). Can financial incentives for improvements in healthcare quality enhance identification of COPD in primary care?. Thorax. 66:630. Author weblink DOI.
  • Hopkinson NS; Li KW; Kehoe A; Humphries SE; Roughton M; Moxham J; Montgomery H; Polkey MI. (1 Feb 2008). Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. AMERICAN JOURNAL OF CLINICAL NUTRITION. 87:385-390. Author weblink.
  • Hopkinson NS; Eleftheriou KI; Payne J; Nickol AH; Hawe E; Moxham J; Montgomery H; Polkey MI. (Apr 2006). +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr. 83:912-917. Author weblink.
  • Hopkinson NS; Toma TP; Hansell DM; Goldstraw P; Moxham J; Geddes DM; Polkey MI. (1 Mar 2005). Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med. 171:453-460. Author weblink DOI.
  • Hopkinson NS; Nickol AH; Payne J; Hawe E; Man WD; Moxham J; Montgomery H; Polkey MI. (15 Aug 2004). Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 170:395-399. Author weblink DOI.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook